Moroni Gabriella, Raffiotta Francesca, Ponticelli Claudio
Unità Operativa di Nefrologia e Dialisi, Fondazione IRCCS Cà Granda Ospedale Policlinico Milano, Via della Commenda 15, 20122, Milano, Italy.
Nephrology Unit, Clinical and Research Center Humanitas, Rozzano, Milano, Italy.
J Nephrol. 2016 Aug;29(4):559-65. doi: 10.1007/s40620-016-0313-6. Epub 2016 May 4.
There is agreement that early diagnosis and aggressive treatment of lupus nephritis exacerbations are of paramount importance to achieve remission and prevent the development of irreversible lesions. There is less agreement about the optimal duration of maintenance treatment. Instead, the prolonged exposure to corticosteroids and/or immunosuppressive drugs can cause invalidating or even life-threatening complications. It is still unclear if these drugs can be safely withdrawn in lupus patients. We were able to completely withdraw therapy in around 1/3 of our patients after a follow-up of 5 years or more; 60 % of them never had to start therapy again. Based on our own experience, discontinuation of therapy should be applied only in selected cases, i.e. patients who received maintenance therapy for at least 5 years and are in complete renal remission for at least 3 years. Antimalarial agents are helpful in maintaining the remission after withdrawal of therapy. However, to achieve these goals, drugs should be tapered off very slowly and under strict surveillance. If all these prerequisites are satisfied, the withdrawal of therapy in patients with lupus nephritis may be considered safe, may improve the patients' quality of life and may reduce the damage accrual.
人们一致认为,狼疮性肾炎病情加重时的早期诊断和积极治疗对于实现缓解以及预防不可逆病变的发展至关重要。对于维持治疗的最佳时长,人们的意见则不太一致。相反,长期使用皮质类固醇和/或免疫抑制药物可能会引发致残甚至危及生命的并发症。狼疮患者能否安全停用这些药物仍不明确。在随访5年或更长时间后,我们能够让约三分之一的患者完全停用治疗;其中60%的患者再也无需重新开始治疗。根据我们自己的经验,仅在特定情况下才应停用治疗,即接受维持治疗至少5年且完全肾脏缓解至少3年的患者。抗疟药有助于在停药后维持缓解状态。然而,为实现这些目标,药物应在严格监测下非常缓慢地减量。如果满足所有这些先决条件,狼疮性肾炎患者停用治疗可能被认为是安全的,可能改善患者的生活质量,并可能减少损害累积。